Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 20 Lymphoma 19 Lymphoma, Large B-Cell, Diffuse 17 Hodgkin Disease 8 Lymphoma, Non-Hodgkin 7 Lymphoma, Follicular 5 Leukemia 5 Hemangioma 5 Lymphoma, Large-Cell, Anaplastic 4 Prostatic Neoplasms 3 Neoplasms 3 Lymphoma, B-Cell 3 Immunoblastic Lymphadenopathy 3 Neurotoxicity Syndromes 2 Neoplasm, Residual 2 Lymphoma, T-Cell, Peripheral 2 Lymphoma, T-Cell 2 Lymphoma, Mantle-Cell 2 Lymphoma, B-Cell, Marginal Zone 2 Esophageal Stenosis 2 Enteropathy-Associated T-Cell Lymphoma 2 Vomiting 1 Thymoma 1 Recurrence 1 Pulmonary Disease, Chronic Obstructive 1 Polycystic Ovary Syndrome 1 Philadelphia Chromosome 1 Neoplasm Metastasis 1 Neoadjuvant Therapy 1 Nausea 1

Interventions

Prednisolone 1 BID protein, human 1 Androgen Antagonists 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Abiraterone Acetate × Prednisolone × Clear all

NCT06768255 2025-01-10

mCRPC

Fudan University

Phase 3 Not yet recruiting

Abiraterone Acetate

Data powered by HemOnc (CC BY 4.0) Colophon ⚡